Cargando…
Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials
Episodic Future Thinking (EFT) reduces delay discounting and may have the potential as a clinical tool to increase the likelihood of health-promoting behaviors. However, evaluations of EFT in clinical settings require control conditions that match the effort and frequency of cue generation, as well...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399790/ https://www.ncbi.nlm.nih.gov/pubmed/37535609 http://dx.doi.org/10.1371/journal.pone.0289478 |
_version_ | 1785084322024259584 |
---|---|
author | Brown, Jeremiah M. Bickel, Warren K. Epstein, Leonard H. Stein, Jeffrey S. |
author_facet | Brown, Jeremiah M. Bickel, Warren K. Epstein, Leonard H. Stein, Jeffrey S. |
author_sort | Brown, Jeremiah M. |
collection | PubMed |
description | Episodic Future Thinking (EFT) reduces delay discounting and may have the potential as a clinical tool to increase the likelihood of health-promoting behaviors. However, evaluations of EFT in clinical settings require control conditions that match the effort and frequency of cue generation, as well as participants’ expectations of improvement. The Health Information Thinking (HIT) control addresses these issues, but how this control affects delay discounting in individuals with diabetes and obesity when utilizing diabetes-management specific health-information vignettes is unknown. Moreover, little research has explored whether EFT reduces delay discounting in individuals with type 2 diabetes. To this end, we examined the impact of EFT, HIT, and a secondary no-cue control condition (NCC; assessments as usual) on delay discounting in 434 adults with self-reported type 2 diabetes and obesity recruited using Amazon Mechanical Turk. After completing an initial screening questionnaire, eligible participants reported demographics, then were randomized to EFT, HIT, or NCC conditions. Following the generation of seven EFT or HIT cues, participants assigned to EFT or HIT conditions completed a delay discounting task while imagining EFT or HIT cues; no-cue participants completed the task without cues. EFT participants demonstrated significantly lower delay discounting levels than HIT or NCC participants; no differences in delay discounting between HIT and NCC participants were observed. These results suggest that engaging in EFT, but not diabetes-specific HIT, results in lower delay discounting in adults with type 2 diabetes and obesity. This provides further evidence for the appropriateness of the HIT control for clinical trials examining the effect of EFT on delay discounting in adults with self-reported type 2 diabetes. |
format | Online Article Text |
id | pubmed-10399790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-103997902023-08-04 Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials Brown, Jeremiah M. Bickel, Warren K. Epstein, Leonard H. Stein, Jeffrey S. PLoS One Research Article Episodic Future Thinking (EFT) reduces delay discounting and may have the potential as a clinical tool to increase the likelihood of health-promoting behaviors. However, evaluations of EFT in clinical settings require control conditions that match the effort and frequency of cue generation, as well as participants’ expectations of improvement. The Health Information Thinking (HIT) control addresses these issues, but how this control affects delay discounting in individuals with diabetes and obesity when utilizing diabetes-management specific health-information vignettes is unknown. Moreover, little research has explored whether EFT reduces delay discounting in individuals with type 2 diabetes. To this end, we examined the impact of EFT, HIT, and a secondary no-cue control condition (NCC; assessments as usual) on delay discounting in 434 adults with self-reported type 2 diabetes and obesity recruited using Amazon Mechanical Turk. After completing an initial screening questionnaire, eligible participants reported demographics, then were randomized to EFT, HIT, or NCC conditions. Following the generation of seven EFT or HIT cues, participants assigned to EFT or HIT conditions completed a delay discounting task while imagining EFT or HIT cues; no-cue participants completed the task without cues. EFT participants demonstrated significantly lower delay discounting levels than HIT or NCC participants; no differences in delay discounting between HIT and NCC participants were observed. These results suggest that engaging in EFT, but not diabetes-specific HIT, results in lower delay discounting in adults with type 2 diabetes and obesity. This provides further evidence for the appropriateness of the HIT control for clinical trials examining the effect of EFT on delay discounting in adults with self-reported type 2 diabetes. Public Library of Science 2023-08-03 /pmc/articles/PMC10399790/ /pubmed/37535609 http://dx.doi.org/10.1371/journal.pone.0289478 Text en © 2023 Brown et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Brown, Jeremiah M. Bickel, Warren K. Epstein, Leonard H. Stein, Jeffrey S. Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials |
title | Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials |
title_full | Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials |
title_fullStr | Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials |
title_full_unstemmed | Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials |
title_short | Episodic future thinking in type 2 diabetes: Further development and validation of the Health Information Thinking control for clinical trials |
title_sort | episodic future thinking in type 2 diabetes: further development and validation of the health information thinking control for clinical trials |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399790/ https://www.ncbi.nlm.nih.gov/pubmed/37535609 http://dx.doi.org/10.1371/journal.pone.0289478 |
work_keys_str_mv | AT brownjeremiahm episodicfuturethinkingintype2diabetesfurtherdevelopmentandvalidationofthehealthinformationthinkingcontrolforclinicaltrials AT bickelwarrenk episodicfuturethinkingintype2diabetesfurtherdevelopmentandvalidationofthehealthinformationthinkingcontrolforclinicaltrials AT epsteinleonardh episodicfuturethinkingintype2diabetesfurtherdevelopmentandvalidationofthehealthinformationthinkingcontrolforclinicaltrials AT steinjeffreys episodicfuturethinkingintype2diabetesfurtherdevelopmentandvalidationofthehealthinformationthinkingcontrolforclinicaltrials |